Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04135352 |
| Title | A Study of Intratumoral/Intralesional Administration of V938 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic or Recurrent Malignancies (V938-001) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme Corp. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ISR | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0002) | San Francisco | California | 94158 | United States | Details | |
| MD Anderson Cancer Center ( Site 0001) | Houston | Texas | 77030 | United States | Details | |
| Huntsman Cancer Institute ( Site 0004) | Salt Lake City | Utah | 84112 | United States | Details | |
| Princess Margaret Cancer Centre ( Site 0010) | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Rambam Health Care Campus-Oncology Division ( Site 0020) | Haifa | 3109601 | Israel | Details | ||
| Chaim Sheba Medical Center ( Site 0021) | Ramat Gan | 5265601 | Israel | Details |